Peptide Reference Database
Clinical reference database covering mechanisms, dosing protocols, combinations, and contraindications.
Want a personalised protocol?
Our AI generator builds a protocol tailored to your profile and goals.
3 peptides
Semaglutide
Ozempic · Wegovy
Long-acting GLP-1 receptor agonist with FDA approval for T2 diabetes and obesity.
Tirzepatide
Mounjaro · Zepbound
Dual GIP/GLP-1 receptor agonist (first in class) with superior weight loss outcomes (~22% body weight) compared to semaglutide in head-to-head trials.
Retatrutide
LY3437943 · Triple Agonist
First-in-class triple GIP/GLP-1/glucagon receptor agonist (Eli Lilly) in Phase 3 trials.
MaraPeptide · Retatrutide & psychology
Silence in the nervous system — how Retatrutide changes your relationship with food, body and self
Psychological transformation on Retatrutide — essay for free!